Oruka Therapeutics (ORKA) News Today $22.61 +2.04 (+9.92%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$21.75 -0.86 (-3.80%) As of 10/8/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ORKA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Oruka Therapeutics files to sell 39.43M shares of common stock for holdersOctober 4, 2025 | msn.comBTIG Research Reiterates "Buy" Rating for Oruka Therapeutics (NASDAQ:ORKA)October 1, 2025 | americanbankingnews.comOruka Therapeutics, Inc. (NASDAQ:ORKA) Receives $42.00 Average PT from BrokeragesOctober 1, 2025 | americanbankingnews.comBTIG Reiterates Oruka Therapeutics (ORKA) Buy RecommendationSeptember 29, 2025 | msn.comLeerink sees greater opportunity for Oruka’s ORKA-002 after MoonLake newsSeptember 29, 2025 | msn.comOruka Therapeutics (NASDAQ:ORKA) Shares Gap Up - What's Next?September 29, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Receives Buy Rating from BTIG ResearchSeptember 29, 2025 | marketbeat.comOruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of "Buy" from BrokeragesSeptember 28, 2025 | marketbeat.comQ3 EPS Forecast for Oruka Therapeutics Increased by AnalystSeptember 22, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Trading Down 6.2% - Here's What HappenedSeptember 20, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Upgraded at Wall Street ZenSeptember 20, 2025 | marketbeat.comOruka Therapeutics, Up 10%, Is Trying To Take On AbbVie's Biggest MoneymakerSeptember 19, 2025 | msn.comOruka Therapeutics (NASDAQ:ORKA) Stock Price Expected to Rise, BTIG Research Analyst SaysSeptember 19, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Shares Gap Up - Still a Buy?September 18, 2025 | marketbeat.comOruka Therapeutics stock surges after positive Phase 1 resultsSeptember 18, 2025 | za.investing.comOruka jumps as lead drug outperforms AbbVie’s Skyrizi in early-stage trialSeptember 18, 2025 | msn.comOruka Therapeutics, Up 9%, Is Trying To Take On AbbVie's Biggest MoneymakerSeptember 18, 2025 | msn.comOruka Therapeutics Stock (ORKA) Soars on New Psoriasis Drug That Could Challenge AbbVie (ABBV)September 18, 2025 | msn.comOruka Therapeutics Secures $180 Million in PIPE Financing to Advance Chronic Skin Disease TreatmentsSeptember 17, 2025 | quiverquant.comQOruka Therapeutics Announces $180 Million Private PlacementSeptember 17, 2025 | globenewswire.comOruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001September 17, 2025 | globenewswire.comOruka Therapeutics (NASDAQ:ORKA) Stock Price Down 5.4% - Here's What HappenedSeptember 14, 2025 | marketbeat.comOMERS ADMINISTRATION Corp Has $461,000 Holdings in Oruka Therapeutics, Inc. $ORKASeptember 5, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Shares Up 6.6% - Time to Buy?September 4, 2025 | marketbeat.comADAR1 Capital Management LLC Purchases Shares of 132,780 Oruka Therapeutics, Inc. $ORKASeptember 4, 2025 | marketbeat.comRedmile Group LLC Cuts Position in Oruka Therapeutics, Inc. $ORKASeptember 4, 2025 | marketbeat.comOruka Therapeutics, Inc. (NASDAQ:ORKA) Given Consensus Recommendation of "Buy" by BrokeragesSeptember 4, 2025 | marketbeat.comBraidwell LP Raises Stake in Oruka Therapeutics, Inc. $ORKASeptember 3, 2025 | marketbeat.comOruka Therapeutics, Inc. $ORKA Shares Bought by Affinity Asset Advisors LLCAugust 28, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Stock Price Down 5.8% - What's Next?August 27, 2025 | marketbeat.comCandriam S.C.A. Purchases Shares of 116,698 Oruka Therapeutics, Inc. $ORKAAugust 26, 2025 | marketbeat.comQ3 EPS Forecast for Oruka Therapeutics Decreased by AnalystAugust 22, 2025 | marketbeat.comOruka Therapeutics initiated with a Buy at Clear StreetAugust 21, 2025 | msn.comOruka Therapeutics (NASDAQ:ORKA) Earns Buy Rating from HC WainwrightAugust 20, 2025 | marketbeat.comOruka Therapeutics (ORKA) Receives a Buy from H.C. WainwrightAugust 19, 2025 | theglobeandmail.comWedbush Forecasts Reduced Earnings for Oruka TherapeuticsAugust 17, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Downgraded by Wall Street Zen to "Sell"August 17, 2025 | marketbeat.comQ3 EPS Forecast for Oruka Therapeutics Reduced by AnalystAugust 16, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Is In A Good Position To Deliver On Growth PlansAugust 15, 2025 | finance.yahoo.comOruka Therapeutics (NASDAQ:ORKA) Trading 7.1% Higher - Here's WhyAugust 15, 2025 | marketbeat.comOruka Therapeutics' (ORKA) "Outperform" Rating Reiterated at WedbushAugust 13, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPSAugust 12, 2025 | marketbeat.comOruka Therapeutics reports Q2 EPS (46c), consensus (43c)August 12, 2025 | msn.comOruka Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 11, 2025 | globenewswire.comOruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Average Recommendation of "Buy" from AnalystsAugust 10, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Trading Down 9.4% - Here's WhyAugust 7, 2025 | marketbeat.comTD Asset Management Inc Decreases Holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA)August 5, 2025 | marketbeat.comJefferies Financial Group Inc. Grows Holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA)August 3, 2025 | marketbeat.comOruka Therapeutics (ORKA) Expected to Announce Earnings on ThursdayJuly 31, 2025 | marketbeat.comOruka Therapeutics stock rises after FDA clears IND for psoriasis drugJuly 22, 2025 | investing.com Get Oruka Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ORKA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ORKA Media Mentions By Week ORKA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORKA News Sentiment▼0.200.63▲Average Medical News Sentiment ORKA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORKA Articles This Week▼14▲ORKA Articles Average Week Get the Latest News and Ratings for ORKA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Oruka Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CDTX News Today OCUL News Today IRON News Today TVTX News Today BLTE News Today AGIO News Today ETNB News Today ARQT News Today MESO News Today DNLI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORKA) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oruka Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oruka Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
